Puma Biotechnology: A Story In Flux Heading Into Mid-2024 [Seeking Alpha]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Seeking Alpha
The company's lone approved product, neratinib, is being marketed for HER2-positive breast cancer, but competition in the HER2 space is fierce. Puma Biotechnology's future outlook remains uncertain, with the success of its pipeline projects, particularly alisertib, being highly risky. Before we begin, I just want to remind you that I have prepared an article on ASCO and the various biotechnology companies that are showing up, you can read that here. There are over 50 companies being represented in the oral sessions, so on what is going to be featured! Topline Summary and Update Puma Biotechnology ( NASDAQ: PBYI ) is the quintessential one-hit-wonder pharmaceutical stock, with a single agent approved across a few indications trying its best to carve out niches in the management of different cancers. I have written optimistically about them in the past, since they had some modest profits but a lot of headwinds. No surprise that many analysts on Seeking Alpha continue to express
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- Puma Biotechnology, Inc. (NASDAQ: PBYI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology, Inc. (NASDAQ: PBYI) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Puma Biotechnology, Inc. (NASDAQ: PBYI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.MarketBeat
- Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
PBYI
Earnings
- 5/2/24 - Beat
PBYI
Analyst Actions
- 5/3/24 - HC Wainwright
PBYI
Sec Filings
- 5/17/24 - Form 8-K
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- PBYI's page on the SEC website